SMMT Share Price Performance
US$16.19
-2.81 (-14.79%)
Price US$16.19
Share Pricen/a
Summit Therapeutics Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 34 Fair Values set on narratives written by author
SMMT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Summit Therapeutics Inc. Key Details
About SMMT
- Founded
- 2003
- Employees
- 159
- CEO
- WebsiteView website
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.
